Roman Necina is the vice president and general manager, viral vector, genomic medicine at Cytiva. In this role, he is responsible for overseeing and ensuring the success of new and innovative products.

Roman studied food and biotechnology in Vienna, Austria. He began his doctoral studies on developing novel affinity chromatography resins and optimizing industrial affinity chromatography. He earned his PhD from Vienna’s University of Natural Resources and Applied Life Sciences.